These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 14081276)

  • 1. THE EFFECT OF AMINOPTERIN SODIUM ON PLASMA FIBRINOGEN, ANTIFIBRINOLYSIN AND EUGLOBULIN LYSIS TIME.
    JOHNSON JF; ZEINEH RA
    Thromb Diath Haemorrh; 1963 Nov; 10():146-50. PubMed ID: 14081276
    [No Abstract]   [Full Text] [Related]  

  • 2. ON THE INTERACTION OF FIBRINOLYSIN (PLASMIN) WITH THE INHIBITORS ANTIFIBRINOLYSIN AND SOYBEAN TRYPSIN INHIBITOR.
    NANNINGA LB; GUEST MM
    Arch Biochem Biophys; 1964 Dec; 108():542-51. PubMed ID: 14244698
    [No Abstract]   [Full Text] [Related]  

  • 3. THE INHIBITORY EFFECT OF LARGE CONCENTRATIONS OF STREPTOKINASE AS RELATED TO PROTEOLYTIC ACTIVITY AND PROACTIVATOR FUNCTION OF HUMAN EUGLOBULIN.
    HELLE I
    Scand J Haematol; 1964; 1():240-56. PubMed ID: 14214904
    [No Abstract]   [Full Text] [Related]  

  • 4. PLASMA EUGLOBULIN LYSIS TIME IN SOME SPECIES OF ANIMALS.
    RAO AR; GOPALAN C
    Indian J Med Res; 1964 Dec; 52():1287-92. PubMed ID: 14264202
    [No Abstract]   [Full Text] [Related]  

  • 5. FIBRINOGEN BREAKDOWN PRODUCTS.
    LEWIS JH; WILSON JH
    Am J Physiol; 1964 Nov; 207():1053-7. PubMed ID: 14237449
    [No Abstract]   [Full Text] [Related]  

  • 6. STUDIES ON THE RELATIONSHIP BETWEEN FIBRIN-STABILIZING FACTOR, CALCIUM AND INHIBITION OF FIBRINOLYSIS.
    TYLER HM; LACK CH
    Clin Sci; 1965 Jun; 28():527-36. PubMed ID: 14316258
    [No Abstract]   [Full Text] [Related]  

  • 7. Diurnal variation in plasma euglobulin activity and fibrinogen levels. Preliminary report.
    HAJJAR GC; WHISSEN NC; MOSER KM
    Angiology; 1961 May; 12():160-4. PubMed ID: 13710622
    [No Abstract]   [Full Text] [Related]  

  • 8. The euglobulin lysis time test: an ineffectual monitor of the therapeutic inhibition of fibrinolysis.
    Katz J; Lurie A; Becker D; Metz J
    J Clin Pathol; 1970 Sep; 23(6):529-32. PubMed ID: 4991001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional characterization of a slow and tight-binding inhibitor of plasmin isolated from Russell's viper venom.
    Cheng AC; Tsai IH
    Biochim Biophys Acta; 2014 Jan; 1840(1):153-9. PubMed ID: 23999090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ACTIVATION OF THE FIBRINOLYTIC SYSTEM IN HUMAN BLOOD BY STREPTOKINASE AND CHANGES IN THIS SYSTEM AND IN THE EUGLOBULIN CLOT LYSIS TIME IN RELATION TO AGE AND SEX.
    KONTTINEN YP
    Scand J Clin Lab Invest; 1965; 17():SUPPL 82:1-111. PubMed ID: 14320094
    [No Abstract]   [Full Text] [Related]  

  • 11. Profibrinolysin, antifibrinolysin, fibrinogen and urine fibrinolytic factors in the human subject.
    GUEST MM
    J Clin Invest; 1954 Nov; 33(11):1553-9. PubMed ID: 13211809
    [No Abstract]   [Full Text] [Related]  

  • 12. [MEASUREMENT OF THE RESISTANCE OF PLASMA TO LYSIS. (NEW TECHNIC FOR THE MEASUREMENT OF INHIBITORS OF PLASMINOGEN ACTIVATION].
    VAIREL E; THELY M
    Hemostase; 1963; 3():271-5. PubMed ID: 14079442
    [No Abstract]   [Full Text] [Related]  

  • 13. INHIBITION OF THE FIBRINOGEN-PLASMIN REACTION BY OMEGA-AMINOCARBOXYLIC ACIDS AND ALKYLAMINES.
    BICKFORD AF; TAYLOR FB; SHEENA R
    Biochim Biophys Acta; 1964 Nov; 92():328-33. PubMed ID: 14249121
    [No Abstract]   [Full Text] [Related]  

  • 14. EFFECT OF PLASMIN ON FIBRINOGEN AND FIBRIN.
    GAJEWSKI J; ALEXANDER B
    Am J Physiol; 1964 Jan; 206():79-82. PubMed ID: 14111457
    [No Abstract]   [Full Text] [Related]  

  • 15. THE ACTION OF PLASMIN ON FIBRINOGEN ADN FIBRIN. I. CHANGES IN THE N-TERMINAL RESIDUES.
    MILLS DA; COYNE R; POLLARA B; VONKORFF RW
    Biochim Biophys Acta; 1964 Jun; 86():527-34. PubMed ID: 14192904
    [No Abstract]   [Full Text] [Related]  

  • 16. [NEUTRALIZATION OF ANTIPLASMIN IN THE BLOOD DURING PROTECTIVE REACTIONS OF THE PHYSIOLOGIC ANTICOAGULATION SYSTEM].
    KUDRIASHOV BA; ANDREENKO GV; KALISHEVSKAIA TM
    Probl Gematol Pereliv Krovi; 1964 Apr; 9():12-5. PubMed ID: 14195816
    [No Abstract]   [Full Text] [Related]  

  • 17. CIRCULATING FIBRINOGEN DEGRADATION PRODUCTS (FDP) IN DOG BLOOD AFTER INTRAVENOUS THROMBIN INFUSION.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1965 Mar; 13():12-24. PubMed ID: 14285962
    [No Abstract]   [Full Text] [Related]  

  • 18. AUTOMATIC DETERMINATION OF LYSIS TIMES.
    NANNINGA LB; ZELLER R; MAYNES C
    J Lab Clin Med; 1964 Oct; 64():706-8. PubMed ID: 14233159
    [No Abstract]   [Full Text] [Related]  

  • 19. Fibrinolysin and antifibrinolysin; biochemical concentration of antifibrinolysin.
    LOOMIS EC; RYDER A; GEORGE C
    Arch Biochem; 1949 Feb; 20(2):444-50. PubMed ID: 18108935
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the difference between serum and euglobulin in determination of fibrinolytic activities by streptokinase-activated method with special reference to the relationship with antiplasmin agents].
    Miyatani K; Fukui I
    Rinsho Byori; 1971 Mar; 19(3):223-6. PubMed ID: 4252723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.